Search

Search Constraints

You searched for: Author/Creator Haderlein, Marlen

Search Results

1. Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1). (January 2020)

2. Combination of growth pattern and tumor regression identifies a high‐risk group in neoadjuvant treated rectal cancer patients. Issue 5 (May 2017)

4. High‐grade histology as predictor of early distant metastases and decreased disease‐free survival in salivary gland cancer irrespective of tumor subtype. (3rd February 2016)

5. Influence of p16 status on indication and outcome of salvage neck dissection in oropharyngeal cancer. (1st February 2021)

6. Long‐Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High‐Risk Bladder Cancer (Ta, Tis, T1, T2). (10th July 2019)

7. PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis. (September 2016)

8. Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy. (November 2020)

9. Regulatory T cells and cytotoxic T cells close to the epithelial–stromal interface are associated with a favorable prognosis. (1st January 2020)

10. Secondary Tracheoesophageal Puncture After Laryngectomy Increases Complications With Shunt and Voice Prosthesis. (6th February 2020)